Cite
Primary Prophylaxis of Disseminated Histoplasmosis in HIV Patients in French Guiana: Arguments for Cost Effectiveness
MLA
Vincent Vantilcke, et al. Primary Prophylaxis of Disseminated Histoplasmosis in HIV Patients in French Guiana: Arguments for Cost Effectiveness. Dec. 2013. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....90aedf616fdf6e067cb1258289c0566b&authtype=sso&custid=ns315887.
APA
Vincent Vantilcke, Célia Basurko, Antoine Adenis, Mathieu Nacher, Christine Aznar, Pierre Couppié, Bernard Carme, & Denis Blanchet. (2013). Primary Prophylaxis of Disseminated Histoplasmosis in HIV Patients in French Guiana: Arguments for Cost Effectiveness.
Chicago
Vincent Vantilcke, Célia Basurko, Antoine Adenis, Mathieu Nacher, Christine Aznar, Pierre Couppié, Bernard Carme, and Denis Blanchet. 2013. “Primary Prophylaxis of Disseminated Histoplasmosis in HIV Patients in French Guiana: Arguments for Cost Effectiveness,” December. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....90aedf616fdf6e067cb1258289c0566b&authtype=sso&custid=ns315887.